Literature DB >> 8670861

Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase.

A L Breeze1, B V Kara, D G Barratt, M Anderson, J C Smith, R W Luke, J R Best, S A Cartlidge.   

Abstract

We have determined the solution structure of the C-terminal SH2 domain of the p85 alpha subunit of human phosphatidylinositol (PI) 3-kinase (EC 2.7.1.137) in complex with a phosphorylated tyrosine pentapeptide sequence from the platelet-derived growth factor receptor using heteronuclear nuclear magnetic resonance spectroscopy. Overall, the structure is similar to other SH2 domain complexes, but displays different detail interactions within the phosphotyrosine binding site and in the recognition site for the +3 methionine residue of the peptide, the side chain of which inserts into a particularly deep and narrow pocket which is displaced relative to that of other SH2 domains. The contacts made within this +3 pocket provide the structural basis for the strong selection for methionine at this position which characterizes the SH2 domains of PI3-kinase. Comparison with spectral and structural features of the uncomplexed domain shows that the long BG loop becomes less mobile in the presence of the bound peptide. In contrast, extreme resonance broadening encountered for most residues in the beta D', beta E and beta F strands and associated connecting loops of the domain in the absence of peptide persists in the complex, implying conformational averaging in this part of the molecule on a microsecond-to-millisecond time scale.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670861      PMCID: PMC451962     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  The C-terminal SH2 domain of p85 accounts for the high affinity and specificity of the binding of phosphatidylinositol 3-kinase to phosphorylated platelet-derived growth factor beta receptor.

Authors:  A Klippel; J A Escobedo; W J Fantl; L T Williams
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

2.  Three-dimensional solution structure of the src homology 2 domain of c-abl.

Authors:  M Overduin; C B Rios; B J Mayer; D Baltimore; D Cowburn
Journal:  Cell       Date:  1992-08-21       Impact factor: 41.582

3.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

4.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.

Authors:  G Waksman; S E Shoelson; N Pant; D Cowburn; J Kuriyan
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

5.  Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding.

Authors:  S A Cunningham; M N Waxham; P M Arrate; T A Brock
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

6.  Solution structure of the fibrin binding finger domain of tissue-type plasminogen activator determined by 1H nuclear magnetic resonance.

Authors:  A K Downing; P C Driscoll; T S Harvey; T J Dudgeon; B O Smith; M Baron; I D Campbell
Journal:  J Mol Biol       Date:  1992-06-05       Impact factor: 5.469

7.  A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor.

Authors:  C Ponzetto; A Bardelli; F Maina; P Longati; G Panayotou; R Dhand; M D Waterfield; P M Comoglio
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

8.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.

Authors:  M J Eck; S E Shoelson; S C Harrison
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

9.  Conformation of two non-immunosuppressive FK506 analogs when bound to FKBP by isotope-filtered NMR.

Authors:  A M Petros; M Kawai; J R Luly; S W Fesik
Journal:  FEBS Lett       Date:  1992-08-24       Impact factor: 4.124

10.  Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.

Authors:  R X Xu; J M Word; D G Davis; M J Rink; D H Willard; R T Gampe
Journal:  Biochemistry       Date:  1995-02-21       Impact factor: 3.162

View more
  13 in total

1.  Alternative modes of binding of proteins with tandem SH2 domains.

Authors:  R O'Brien; P Rugman; D Renzoni; M Layton; R Handa; K Hilyard; M D Waterfield; P C Driscoll; J E Ladbury
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

2.  Specificity and affinity motifs for Grb2 SH2-ligand interactions.

Authors:  Helmut W H G Kessels; Alister C Ward; Ton N M Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

3.  Binding of a diphosphorylated-ITAM peptide to spleen tyrosine kinase (Syk) induces distal conformational changes: a hydrogen exchange mass spectrometry study.

Authors:  M Isabel Catalina; Marcel J E Fischer; Frank J Dekker; Rob M J Liskamp; Albert J R Heck
Journal:  J Am Soc Mass Spectrom       Date:  2005-07       Impact factor: 3.109

4.  Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.

Authors:  Pijus K Mandal; Donald Limbrick; David R Coleman; Garrett A Dyer; Zhiyong Ren; J Sanderson Birtwistle; Chiyi Xiong; Xiaomin Chen; James M Briggs; John S McMurray
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

5.  Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation.

Authors:  C Béraud; W J Henzel; P A Baeuerle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

6.  Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domains.

Authors:  Jennifer Y Lee; Yu-Hsin Chiu; John Asara; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

7.  Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain.

Authors:  K Ogura; S Tsuchiya; H Terasawa; S Yuzawa; H Hatanaka; V Mandiyan; J Schlessinger; F Inagaki
Journal:  J Biomol NMR       Date:  1997-10       Impact factor: 2.835

8.  Two closely spaced tyrosines regulate NFAT signaling in B cells via Syk association with Vav.

Authors:  Chih-Hong Chen; Victoria A Martin; Nina M Gorenstein; Robert L Geahlen; Carol Beth Post
Journal:  Mol Cell Biol       Date:  2011-05-23       Impact factor: 4.272

9.  Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.

Authors:  Monika Ivancic; Roger J Daly; Barbara A Lyons
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

Review 10.  Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug design.

Authors:  Sandra B Gabelli; Diana Mandelker; Oleg Schmidt-Kittler; Bert Vogelstein; L Mario Amzel
Journal:  Biochim Biophys Acta       Date:  2009-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.